Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients

Clinical Trial ID NCT01611974

PubWeight™ 6.40‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01611974

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Differential properties of cytomegalovirus pUL97 kinase isoforms affect viral replication and maribavir susceptibility. J Virol 2014 0.87
2 Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol 2014 0.85
3 Cytomegalovirus pneumonia in hematopoietic stem cell recipients. J Intensive Care Med 2013 0.83
4 Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient. BMC Infect Dis 2013 0.82
5 Cytomegalovirus infection in liver transplant recipients: updates on clinical management. World J Gastroenterol 2014 0.80
6 Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2016 0.78
7 Potential of protein kinase inhibitors for treating herpesvirus-associated disease. Trends Microbiol 2013 0.76
8 CMV in Hematopoietic Stem Cell Transplantation. Mediterr J Hematol Infect Dis 2016 0.75
Next 100